Longer-term follow-up of a phase 2 study (Checkmate 063) of nivolumab in patients with advanced refractory squamous (SQ) non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Horn, L.; Rizvi, N.; Mazieres, J.; Planchard, D.; Stinchcombe, T. E.; Dy, G. K.; Antonia, S. J.; Lena, H.; Minenza, E.; Mennecier, B.; Otterson, G. A.; Campos, L. T.; Gandara, D. R.; Levy, B. P.; Nair, S. G.; Zalman, G.; Wolf, J.; Paik, P.; Zhu, J.; Xu, D.; Neely, J.; Qi, Z. H.; Harbison, C. T.; Lynch, M.; Ramalingam, S. S. |
| Abstract Title: | Longer-term follow-up of a phase 2 study (Checkmate 063) of nivolumab in patients with advanced refractory squamous (SQ) non-small cell lung cancer (NSCLC) |
| Meeting Title: | COSA's 42nd Annual Scientific Meeting |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 11 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2015 Nov 17-19 |
| Meeting Location: | Hobart, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2015-11-01 |
| Start Page: | 124 |
| Language: | English |
| ACCESSION: | WOS:000364320800176 |
| PROVIDER: | wos |
| PUBMED: | 26525766 |
| DOI: | 10.1111/ajco.12432_2 |
| Notes: | Meeting Abstract: 200 -- SI -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
